BARD1 is developing a pipeline of cancer diagnostic and therapeutic products based on its proprietary BARD1 technology. Our lead product the BARD1 Lung Cancer Test is a non-invasive blood test in development for early detection of lung cancer. We are also researching a high-value pipeline of potential diagnostic and therapeutic candidates for unmet needs in multiple cancers.

Diagnostics Pipeline

Therapeutics Pipeline